Clinical Trials Browser

Phase 1/2 × Recurrence × SHR-1701 × Clear all

NCT05896046 2023-06-15

SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma

Phase 1/2 Recruiting

Hodgkin Disease, Recurrence

NCT05503888 2022-08-17

Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer

Phase 1/2 Not yet recruiting

Recurrence